Who owns ELIEM THERAPEUTICS INC?
- Ticker: ELYM
- CUSIP Number: 28658r106
Tip: Access positions for across all investors
Analyze quarterly positions in Eliem Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eliem Therapeutics stock
Who bought or sold ELIEM THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 13M | $36M | 0% | Dec 2023 |
|
| BML Capital Management | 2.2M | $5.9M | 12% | Dec 2023 |
|
| Vanguard Group | 311k | $838k | 0% | Dec 2023 |
|
| Tudor Investment Corporation | 30k | $80k | -1% | Dec 2023 |
|
| Millennium Management | 18k | $49k | -68% | Dec 2023 |
|
| HPM Partners | 14k | $37k | 100% | Dec 2023 |
|
| Chicago Partners Investment | 12k | $36k | -5% | Dec 2023 |
|
| Advisor Group Holdings | 8.3k | $23k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 48.00 | $129.998400 | 7% | Dec 2023 |
|
| Royal Bank of Canada | 36.00 | $0 | -36% | Dec 2023 |
|
| Bank of America Corporation | 3.00 | $8.000100 | -100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 1.00 | $3.000000 | 100% | Dec 2023 |
|
Who sold out of Eliem Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Stifel Financial | Sep 2023 | 15k | $39k |
| UBS Group | Sep 2023 | 89.00 | $233.998800 |